4//SEC Filing
Pauli Ronald 4
Accession 0001209191-18-028364
CIK 0001492426other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 5:03 PM ET
Size
13.3 KB
Accession
0001209191-18-028364
Insider Transaction Report
Form 4
Pauli Ronald
Director
Transactions
- Award
Restricted Stock Units
2018-05-03+15,320→ 15,320 totalFrom: 2019-05-03→ Ordinary shares (15,320 underlying) - Exercise/Conversion
Ordinary Shares
2018-05-03+14,054→ 28,084 total(indirect: By Trust) - Tax Payment
Ordinary Shares
2018-05-03$13.87/sh−3,790$52,567→ 24,294 total(indirect: By Trust) - Exercise/Conversion
Restricted Stock Units
2018-05-03−14,054→ 0 total→ Ordinary shares (14,054 underlying) - Award
Stock Option (Right to Buy)
2018-05-03+32,161→ 32,161 totalExercise: $13.87Exp: 2028-05-02→ Ordinary shares (32,161 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- [F2]On May 3, 2017, the reporting person was granted 14,054 restricted stock units, vesting in full on the first anniversary of the grant date.
- [F3]The option vests in 12 equal monthly installments from the date of grant.
Documents
Issuer
Horizon Pharma plc
CIK 0001492426
Entity typeother
Related Parties
1- filerCIK 0001364475
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 5:03 PM ET
- Size
- 13.3 KB